featured
Nivolumab Plus Ipilimumab for Stage IV Squamous Cell Lung Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical Trial
JAMA Oncol 2021 Jul 15;[EPub Ahead of Print], SN Gettinger, MW Redman, L Bazhenova, FR Hirsch, PC Mack, LH Schwartz, JD Bradley, TE Stinchcombe, NB Leighl, SS Ramalingam, SS Tavernier, H Yu, JM Unger, K Minichiello, L Highleyman, VA Papadimitrakopoulou, K Kelly, DR Gandara, RS HerbstFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.